Comparative Efficacy for Infliximab vs. Vedolizumab in Biologic Naive Ulcerative Colitis. Narula N, Wong ECL, Marshall JK, Colombel JF, et al. Clin Gastroenterol Hepatol 2021 Jul 27. pii: S1542-3565(21)00820.

Read + Share

Amedeo Smart

Independent Medical Education

Narula N, Wong ECL, Marshall JK, Colombel JF, et al. Comparative Efficacy for Infliximab vs. Vedolizumab in Biologic Naive Ulcerative Colitis. Clin Gastroenterol Hepatol 2021 Jul 27. pii: S1542-3565(21)00820.
PMID: 34329776